Microfluidic Technology News
-
Amerigo Scientific's New Lab Offering: S-Silver SERS Substrates
Amerigo Scientific, a distributor focused on providing critical products and services to biomedical and life science communities, announced the launch of its latest innovation in the field of surface-enhanced Raman spectroscopy (SERS) – S-Silver SERS substrates. With this exciting addition to its extensive product portfolio, Amerigo Scientific aims to empower researchers, scientists, and ...
-
Alfa Chemistry Celebrates Thanksgiving Day and Christmas with Festival Sale for All Products and Services
As Thanksgiving Day and Christmas are around the corner, Alfa Chemistry, a chemical supplier located in Ronkonkoma, NY, USA, recently announced the launch of a festival sale to express its sincere gratitude to global customers for 2022. With effortless endeavors, Alfa Chemistry has successfully diversified its product and service portfolios over the past year. Currently, its business range has ...
-
Curate Biosciences Announces David Backer as Chief Executive Officer
Curate Biosciences, a key enabling technology company for cell therapy manufacturing, today announced that David M. Backer will become the Company's next chief executive officer (CEO) and a member of Curate's Board of Directors. Backer brings decades of cell and gene therapy experience to the company as it looks to accelerate the production of life-saving medicines and change health outcomes for ...
-
Curate Biosciences Adds Mayo Pujols to its Board of Directors
Curate Biosciences, a key enabling technology company for cell therapy manufacturing, today announced that Mayo Pujols, Chief Technical Officer of late-stage gene therapy biotech Rocket Pharmaceuticals, has been appointed to its Board of Directors. Mr. Pujols has worked in biopharmaceutical manufacturing for nearly thirty years including managing cell and gene therapy manufacturing operations for ...
-
Curate Biosciences Appoints Daniel Getts, Ph.D. to its Board of Directors
Curate Biosciences, a key enabling technology company for cell therapy manufacturing, today announced that Daniel Getts, Ph.D., cofounder and CEO of Myeloid Therapeutics, has been appointed to its Board of Directors. Dr. Getts is an immunologist by training and a serial entrepreneur with a proven track record in building and financing companies focused on creating next-generation immunotherapies. ...
-
Handix Scientific Inc. Completes Acquisition of Aerosol Devices Inc.
Handix Scientific Inc. announced that on June 30, 2022 the company acquired Aerosol Devices Inc (“ADev”). Both companies were founded in the State of Colorado and are headquartered in Fort Collins. Founded in 2014, ADev owns an exclusive license to the airborne particle collectors based on the water-based condensational growth tube (“CGT”) technology invented by Aerosol ...
-
CellFE unveils research scale microfluidics-based cell engineering platform at BIO2022
The BIO International Convention (BIO) returns to in person meetings in San Diego, CA June 13-16 and CellFE will be there to present the research scale system currently being evaluated by clients and collaborators. Exhibiting at BIO is a key step in the commercialization of CellFE’s cell engineering platform and is a chance for potential partners to learn about this unique approach and ...
By CellFE
-
Interpace Biosciences Announces First Quarter 2022 Financial and Business Results D
Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the first quarter ended March 31, 2022 and provided a business and financial update. First quarter Net Revenue was $10.4 million, a 6% increase as compared to the same period of 2021. Our Net Loss in the first quarter of 2022 was $2.2 million, which represents an ...
-
Miroculus to Optimize Automated Next Generation Sequencing Library Preparation with Interpace Diagnostics and Twist Bioscience
Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”), a leader in enabling personalized medicine, has announced that in association with Miroculus, Inc., a developer of revolutionary tools for personal lab automation, it will optimize next generation sequencing (NGS) library preparation utilizing its digital microfluidics (DMF) technology. Also working ...
-
Alfa Chemistry Launches a Chemistry-Focused Technology Platform: Advanced and Flexible
In this brand new year of 2022, Alfa Chemistry wishes to extend its sincere gratitude to its customers worldwide for their continuing support in the past years. While maintaining to be a trust-worthy supplier of all varieties of chemicals, the company decides to play a more active role in chemistry services and thus launches an advanced and flexible chemistry-focused technology platform, offering ...
-
Alfa Chemistry Announces Offering and Customized Manufacturing of Microfluidic Devices for Experimental Research
Microfluidics is a very helpful tool in the biological sciences to conduct precise and controlled experiments at a faster pace and with lower cost. Alfa Chemistry recently announces to offer a wide range of microfluidic devices, including glass chips, microfluidic polymer chips, and many other functional chips Microfluidic devices have microchannels ranging from submicron to few millimeters. ...
-
Alfa Chemistry Microfluidics: Transform Amazing Microfluidics Idea into Reality
The past decade has seen microfluidics as a distinct new area of research, which found widespread applications in chemistry, biology, medicine, physical sciences as well as many other fields. Being an active player in the biotechnology industry, Alfa Chemistry recently launches a sub-website specially focusing on microfluidics research. The products and services provided are aiming to transform ...
-
Redbud Labs announces NAxtract™, an automated sample preparation platform
Redbud Labs announced NAxtract™, a fully automated sample preparation solution for low- to medium- throughput applications. NAxtract enables automation of gold-standard workflows in environments where previously the only viable option was manual processing. NAxtract is ideal for labs that work with precious sample types, that require fast turnaround times, and that offer esoteric ...
By Redbud Labs
-
AG Industries Welcomes Kyle Jandrasitz, New VP of Sales and Marketing
We are continuously looking for ways to better serve our customers and strengthen our position in our target markets. To capitalize on growth opportunities within our organization, I am pleased to announce that Kyle Jandrasitz is joining AG Industries effective November 16 as VP, Sales & Marketing. In this newly created position, Kyle will partner with key leaders across the AG business to ...
-
Barriers to sequencing for everyday diagnostics
If it wasn’t clear before COVID-19, it is now: ubiquitous, worldwide testing for infectious diseases is crucial for public health and prosperity. Nucleic acid amplification tests (NAATs) are the gold standard for infectious disease diagnosis. Unfortunately, NAATs are a game of whack-a-mole: you have to know what disease you’re looking for in order to develop a test to diagnose it. ...
By Redbud Labs
-
High-performance sample prep on-cartridge
Any developer of a sample-to-answer device knows that getting sample prep working on-cartridge is a major source of risk. It makes matters worse that issues with sample prep usually arise late in the development process. Sample prep is often responsible when product development runs over time and over budget. Sample prep surprises often occur when developers transition a working benchtop ...
By Redbud Labs
-
Sample prep method considerations for sample-to-answer systems
System developers are faced with designing systems to deliver consistent, high quality results, faster. Scientists and engineers must work achieve their specifications while keeping development and production costs down. One cost driver for development cost and timeline is the challenge of transitioning laboratory methods to cartridges. Porting sample prep to a microfluidic system, in ...
By Redbud Labs
-
Translating Laboratory Performance to Your Point-of-care Device
Across the life sciences, the pressure to achieve faster results, and reduce costs, is driving a transition to sample-to-answer platforms. Molecular diagnostics are moving from industrial liquid handling systems to point-of-care devices. The next generation of bioprocessing systems are leaving behind the vast bioreactors of the past in favor of automated, end-to-end cell production. Sequencing is ...
By Redbud Labs
-
Lumex Instruments presentation on streaming potential option captivates audience at LACE 2018
Lumex Instruments Canada took part in the capillary electrophoresis symposium for Latin America. Our expert, the capillary electrophoresis (CE) project manager Dr. Vadim M. Okun, Ph.D., gave his presentation about a very interesting and exciting topic: NEW PERSPECTIVES IN PERFORMING LONG SEQUENCES OF CAPILLARY ELECTROPHORESIS ANALYSES USING STREAMING POTENTIAL CONTROL. The streaming potential ...
-
Technical Problems Problems Caused by Air Bubbles in Microfluidic Systems
Air bubbles could form in microfluidic systems for many reasons, such as inappropriate channel design. In some cases these bubbles are intentionally generated, because they have many beneficial features, e.g., flow control, mixing enhancement, pumping improvement. Nevertheless, air bubbles are usually very harmful to microfluidic systems, especially in long-term cell culture experiments, ...
By Chemyx Inc
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you